Research Article
BibTex RIS Cite
Year 2017, Volume: 3 Issue: 2, 20 - 24, 28.08.2017
https://doi.org/10.19127/mbsjohs.309464

Abstract


References

  • 1. Nagata S, Golstein P. The Fasdeathfactor. Science.1995; 267:1449 –1456.
  • 2. Cohen JJ: Programmed cell death in the immune system. AdvImmunol. 1991; 50: 55-58.
  • 3. Wilson KF, Meier JD, Ward PD. Salivary gland disorders. Am Fam Physician. 2014;89(11):882-8.
  • 4. Tarpley, T. M.,Jr, Anderson, L. G. and White, C. L. Minor salivary gland involvement in Sjogren’s syndrome. Oral Surg. Oral Med. Oral Pathol.1974;.37:64.
  • 5. Carracedo, G.,Peral, A. And Pintor, J. Diadenosine polyphosphates in tears of Sjogren syndrome patients. Invest Ophthalmol. Vis. Sci. 2010;51:5452.
  • 6. Sisto, M., Lisi, S., Lofrumento, D., D’Amore, M., Scagliusi, P. AndMitolo, V. Autoantibodies from Sjogren’s syndrome trigger apoptosis in salivary gland cell line. Ann. N. Y. Acad. Sci. 2007;1108:418.
  • 7. Ramos-Casals, M. and Font, J. Primary Sjogren’s syndrome: current and emergentaetiopathogenic concepts. Rheumatology (Oxford) 2005;44:1354.
  • 8. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226(4678):1097-1099.
  • 9. Sasi N, Hwang M, Jaboin J, Csiki I, Lu B: Regulated cell death pathways: new twists in modulation of BCL2 family function. Mol Cancer Ther 2009; 8(6):1421-1429.
  • 10. Cotter TG: Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009; 9(7):501-507.
  • 11. Certo M, Del GaizoMoore V, Nishino M, Wei G, Korsmeyer S, Armstrong SA, et al: Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006; 9(5):351-365.
  • 12. H.H. Xia, G.S. Zhang, N.J. Talley, B.C. Wong, Y. Yang, C. Henwood, J.M. Wyatt, S. Adams, K. Cheung, B. Xia, Y.Q. Zhu, S.K. Lam Am. J. Gastroenterol. 2002; 97 (12), pp. 3023–3031.
  • 13. Şule Bulut, Hilal Uslu, B Handan Özdemir, Ömer Engin Bulut. Expression of caspase-3, p53 and Bcl-2 in generalized aggressive periodontitis. Head&Face Medicine 2006;2:17.
  • 14. MT Abou Elkhier, RR EL-Zehary, MI Mourad, NT Abou El-Khier. Immunohistochemical assessment of Bcl-2 and Ki-67 in gingival tissues of normal and immunosuppressed patients as predictors of neoplasia. Annals of Oral & Maxillofacial Surgery 2014 Jul 10;2(2):14.
  • 15. Ogasawara, Takefumi, et al. "Sclerosing polycystic adenosis with intraluminal crystalloids of the buccal mucosa: A case report and review of the literature." Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 27.4 (2015): 580-587.
  • 16. Bascones A, Gamanol J, Gomez M, Silva A, Gonzalez MA: New knowledge of the pathogenesis of periodonta disease. QuintessenceInt2004;35:706-716.
  • 17. Senturk N, Yildiz L, Sullu Y, Kandemir B, TuranliAY.Expression of bcl-2 protein in active skin lesion of Behçet’s disease Int J Dermatol. 2001;40(12):747-50.
  • 18. Wang YH, Yan Y, Rice JS, Volpe BT, Diamond B.Enforced expression of the apoptosis inhibitor bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism J Autoimmun. 2011;37(1):18-27.
  • 19. Arreaza AJ, Rivera H, Correnti M. Expressionof COX-2 and bcl-2 in oral lichen planus lesions and lichenoid reactions. Ecancermedical science. 2014;8:411.
  • 20. Qi G, Hua H, Gao Y, Lin Q, Yu GY. Sialoadenitis progression in nonobese diabetic mice and its correlation with expression of apoptosis-associated proteins in salivary glands and serum IgG levels. . Chin Med J (Engl). 2007;120(16):1426-31.
  • 21. Polihronis M,Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM. Modes of epithelial cell death and repair in Sjögren's syndrome (SS). ClinExpImmunol 1998; 114:485–490.
  • 22. Robert E. Gerstenbluth, Allen D. Seftel Gregory T. Mac Lennan, R. NagarjunRao, Eric W.Corty, Kelly Ferguson, Martin I. Resnick. Distribution of Chronic Prostatitis in Radical Prostatectomy Specimens With Up-Regulation of BCL-2 in Areas of Inflammation .J Urol. 2002;167(5):2267-70.

Relationship Between BCL-2 and Ki-67 in Chronic Sialadenitis

Year 2017, Volume: 3 Issue: 2, 20 - 24, 28.08.2017
https://doi.org/10.19127/mbsjohs.309464

Abstract

Objective: Apoptosis
or programmed cell death can be triggered by a variety of physiological and
pathological signals. B-cell lymphoma-2 (Bcl-2) is an important anti-apoptotic
protein of apoptosis pathways, mainly localized in intracellular membranes in
mitochondrial outer membrane nuclear membrane and endoplasmic reticulum. BCL-2
family molecules can be stocked by upstream with irreversible cellular damage
sites and have an important role in apoptosis studies. The best known antibody
for identifying proliferating cells is Ki-67. There is a clear correlation
between Ki-67 and the number of mitoses. Ki-67 is a nuclear protein that is
believed to play a role in the early stages of rRNA synthesis ex- pressed in
the G1, S, G2 and M phases except for the G0 phase of the cell cycle. In this
study, we evaluated the expression of BCL-2 and Ki-67 in the pathogenesis of
chronic sialadenitis.

Methods: This study
was included 18 cases of chronic sialadenitis. The immunohistochemistry BCL-2
and Ki-67 antibodies was performed in cases.

Results:
Statistically, there were significant correlation between BCL-2 and Ki-67
expression in acinar cells (p= 0.016). There was significant correlation
between BCL-2 and Ki-67 expression in ductus and epimyoepithelial islands (p=
0.017). There was significant correlation between ductal and acinar cells on
account of Ki-67 expression (p= 0.010).







Conclusion: In this
study, it was seen that decrease of BCL-2 and Ki-67 expression in acinar cells
was higher than ductal epithelial cells. 

References

  • 1. Nagata S, Golstein P. The Fasdeathfactor. Science.1995; 267:1449 –1456.
  • 2. Cohen JJ: Programmed cell death in the immune system. AdvImmunol. 1991; 50: 55-58.
  • 3. Wilson KF, Meier JD, Ward PD. Salivary gland disorders. Am Fam Physician. 2014;89(11):882-8.
  • 4. Tarpley, T. M.,Jr, Anderson, L. G. and White, C. L. Minor salivary gland involvement in Sjogren’s syndrome. Oral Surg. Oral Med. Oral Pathol.1974;.37:64.
  • 5. Carracedo, G.,Peral, A. And Pintor, J. Diadenosine polyphosphates in tears of Sjogren syndrome patients. Invest Ophthalmol. Vis. Sci. 2010;51:5452.
  • 6. Sisto, M., Lisi, S., Lofrumento, D., D’Amore, M., Scagliusi, P. AndMitolo, V. Autoantibodies from Sjogren’s syndrome trigger apoptosis in salivary gland cell line. Ann. N. Y. Acad. Sci. 2007;1108:418.
  • 7. Ramos-Casals, M. and Font, J. Primary Sjogren’s syndrome: current and emergentaetiopathogenic concepts. Rheumatology (Oxford) 2005;44:1354.
  • 8. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226(4678):1097-1099.
  • 9. Sasi N, Hwang M, Jaboin J, Csiki I, Lu B: Regulated cell death pathways: new twists in modulation of BCL2 family function. Mol Cancer Ther 2009; 8(6):1421-1429.
  • 10. Cotter TG: Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009; 9(7):501-507.
  • 11. Certo M, Del GaizoMoore V, Nishino M, Wei G, Korsmeyer S, Armstrong SA, et al: Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006; 9(5):351-365.
  • 12. H.H. Xia, G.S. Zhang, N.J. Talley, B.C. Wong, Y. Yang, C. Henwood, J.M. Wyatt, S. Adams, K. Cheung, B. Xia, Y.Q. Zhu, S.K. Lam Am. J. Gastroenterol. 2002; 97 (12), pp. 3023–3031.
  • 13. Şule Bulut, Hilal Uslu, B Handan Özdemir, Ömer Engin Bulut. Expression of caspase-3, p53 and Bcl-2 in generalized aggressive periodontitis. Head&Face Medicine 2006;2:17.
  • 14. MT Abou Elkhier, RR EL-Zehary, MI Mourad, NT Abou El-Khier. Immunohistochemical assessment of Bcl-2 and Ki-67 in gingival tissues of normal and immunosuppressed patients as predictors of neoplasia. Annals of Oral & Maxillofacial Surgery 2014 Jul 10;2(2):14.
  • 15. Ogasawara, Takefumi, et al. "Sclerosing polycystic adenosis with intraluminal crystalloids of the buccal mucosa: A case report and review of the literature." Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 27.4 (2015): 580-587.
  • 16. Bascones A, Gamanol J, Gomez M, Silva A, Gonzalez MA: New knowledge of the pathogenesis of periodonta disease. QuintessenceInt2004;35:706-716.
  • 17. Senturk N, Yildiz L, Sullu Y, Kandemir B, TuranliAY.Expression of bcl-2 protein in active skin lesion of Behçet’s disease Int J Dermatol. 2001;40(12):747-50.
  • 18. Wang YH, Yan Y, Rice JS, Volpe BT, Diamond B.Enforced expression of the apoptosis inhibitor bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism J Autoimmun. 2011;37(1):18-27.
  • 19. Arreaza AJ, Rivera H, Correnti M. Expressionof COX-2 and bcl-2 in oral lichen planus lesions and lichenoid reactions. Ecancermedical science. 2014;8:411.
  • 20. Qi G, Hua H, Gao Y, Lin Q, Yu GY. Sialoadenitis progression in nonobese diabetic mice and its correlation with expression of apoptosis-associated proteins in salivary glands and serum IgG levels. . Chin Med J (Engl). 2007;120(16):1426-31.
  • 21. Polihronis M,Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM. Modes of epithelial cell death and repair in Sjögren's syndrome (SS). ClinExpImmunol 1998; 114:485–490.
  • 22. Robert E. Gerstenbluth, Allen D. Seftel Gregory T. Mac Lennan, R. NagarjunRao, Eric W.Corty, Kelly Ferguson, Martin I. Resnick. Distribution of Chronic Prostatitis in Radical Prostatectomy Specimens With Up-Regulation of BCL-2 in Areas of Inflammation .J Urol. 2002;167(5):2267-70.
There are 22 citations in total.

Details

Subjects Health Care Administration
Journal Section Research articles
Authors

Ali Aslan

Havva Erdem

Yasin Yağız This is me

Hilal Balta This is me

Publication Date August 28, 2017
Published in Issue Year 2017 Volume: 3 Issue: 2

Cite

Vancouver Aslan A, Erdem H, Yağız Y, Balta H. Relationship Between BCL-2 and Ki-67 in Chronic Sialadenitis. Mid Blac Sea J Health Sci. 2017;3(2):20-4.

2310022108  22107  22106  22105  22103  22109 22137 22102  22110    e-ISSN 2149-7796